Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.24.1.1.u2
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Revenues, net of discounts $ 41,564 $ 36,753  
Gross profit (loss) 17,201 15,512  
Depreciation and amortization 5,883 6,454  
Write-downs and other charges, net 397 516  
Net loss (13,998) (18,595)  
Segment, Expenditure, Addition to Long-Lived Assets 878 1,002  
Purchase of other intangible assets 16 5  
Assets 273,776   $ 277,407
Eastern Region      
Segment Reporting Information [Line Items]      
Revenues, net of discounts 30,226 22,011  
Gross profit (loss) 13,356 10,621  
Depreciation and amortization 4,007 4,472  
Write-downs and other charges, net 16 (1)  
Net loss (981) (5,914)  
Segment, Expenditure, Addition to Long-Lived Assets 833 989  
Assets 213,700   215,743
Western Region      
Segment Reporting Information [Line Items]      
Revenues, net of discounts 11,338 14,565  
Gross profit (loss) 3,845 5,172  
Depreciation and amortization 1,758 1,853  
Write-downs and other charges, net 61 0  
Net loss (635) (440)  
Segment, Expenditure, Addition to Long-Lived Assets 39 10  
Assets 47,612   51,148
Other      
Segment Reporting Information [Line Items]      
Revenues, net of discounts [1] 0 177  
Gross profit (loss) 0 (281)  
Depreciation and amortization 118 129  
Write-downs and other charges, net 320 517  
Net loss (12,382) (12,241)  
Segment, Expenditure, Addition to Long-Lived Assets 6 3  
Purchase of other intangible assets 16 $ 5  
Assets $ 12,464   $ 10,516
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments. The Company has deconsolidated results from its Vermont and CBD operations as of March 8, 2023 and May 8, 2023, respectively.